Physician profile
Christopher Doumas
NPI 1235295239
$2,459.77
in general payments reported to CMS, 2019-2025
13 companies · $471 in 2025
The $471 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $124 · 2021: $195 · 2022: $940 · 2023: $143 · 2024: $218 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $451 · Food and Beverage: $382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $450.59 |
| Food and Beverage | $381.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $870.65 | 2019-2025 | Pangea, Gamma |
| Globus Medical, INC. | $587.80 | 2022 | |
| Encore Medical, Lp | $321.25 | 2022 | |
| Depuy Synthes Sales INC. | $152.79 | 2019-2024 | Dynatape |
| Acumed LLC | $123.85 | 2020 | |
| Dynasplint Systems INC. | $121.71 | 2021 | |
| Seapearl East, INC | $81.06 | 2019 | |
| Medtronic, INC. | $73.27 | 2021 | |
| Medacta USA, INC. | $65.38 | 2023 | Reverse Shoulder |
| Linvatec Corporation | $18.44 | 2023 | Biobrace 23mm |
| Boston Scientific Corporation | $16.65 | 2022 | |
| Innovation Technologies INC | $14.42 | 2022 | |
| Zimmer Biomet Holdings, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Doumas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.